Experimental coronavirus vaccine interim trial report; exercise protein and age-related cognitive decline; scar tissue after a heart attack

July 21, 2020 Edition

COVID-19 is an emerging, rapidly evolving situation, and we at NIH are doing everything we can toward the development of diagnostics, therapeutics, and vaccines. You can findthe latest public health information from CDC at www.coronavirus.govand the latest research information from NIH atwww.nih.gov/coronavirus. Meanwhile, science continues to progress on many other fronts, and we will continue to try to bring you stories across a wide range of topics.

SARS-CoV-2 virus particles

Experimental coronavirus vaccine is safe and produces immune response

Early results from the first COVID-19 vaccine candidate tested in people showed that it triggered an immune response against the virus with no serious side effects.


Group of senior adults on a walk through the park on a sunny day

Exercise-induced protein may reverse age-related cognitive decline

Researchers found that an exercise-induced protein may restore age-related loss of memory and new brain cell growth.


Electron micrographs of scar tissue

Stopping scar tissue improves healing after heart attack in mice

Mice deficient in a certain protein formed larger scars after a heart attack and had worse heart function. The study suggests an approach to improve heart function after heart attack.


Popular Stories

Connect with Us

FB

Facebook

RM Feed

RSS Feed


This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) 9000 Rockville Pike Bethesda MD 20892 301-496-4000 / TTY 301-402-9612 GovDelivery logo